Skip to main content
. 2019 Jan 4;8(1):44. doi: 10.3390/jcm8010044

Figure 5.

Figure 5

Effects of pirfenidone (PFD) treatment on prostate-specific antigen (PSA) secretion from human prostate cancer cells. The level of PSA secreted from LNCaP cells was determined by measuring the PSA level in LNCaP conditioned medium by ELISA. Values represent the means ± standard deviation. *, p < 0.05 versus the vehicle-treated control.